PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 15, 2026Frontiers in Pharmacology0 citationsOpen Access

Correction: miRNA101a secreted by EATMs regulates atrial fibrillation through the PDGF-mediated PI3K/AKT pathway

ZSZheng SihaoLXLi XiaoliangYHYue Honghua

Key Result

Patients with atrial fibrillation had significantly lower expression of miRNA101a in the left atrial appendage epicardial adipose tissue and peripheral blood compared to the control group.

Key Points

  • The study aims to investigate the role of miRNA101a in atrial fibrillation (AF) and its association with myocardial fibrosis.
  • Evaluated miRNA101a expression levels in clinical tissue samples from patients with AF and sinus rhythm using RT-PCR.
  • Conducted animal experiments with rats subjected to esophageal pacing to create an AF model, measuring miRNA101a levels in epicardial adipose tissue.
  • Performed histological analyses (HE and Masson staining) on LAA tissues to assess cellular structure and fibrosis.
  • miRNA101a expression significantly reduced in the LAA epicardial adipose tissue of AF patients compared to the control group (p < 0.05).
  • Animal experiments confirmed reduced miRNA101a levels in AF model rats compared to controls, indicating a similar trend as observed in human samples.
  • Histological analysis showed increased inflammatory cell infiltration and collagen deposition in the AF group, supporting the link to myocardial fibrosis.

PICO

P
Population
atrial fibrillation
O
Primary Outcome
miRNA101a expression levels

Abstract

In this study, we observed (Figure 1A) a significant reduction in the expression of miRNA101a in the LAA epicardial adipose tissue and peripheral blood of patients with AF compared to the control group. This was determined by RT-PCR analysis of clinical tissue samples from the LAA, showing that miRNA101a levels were higher in the AF group than in the SR group, with the difference being statistically significant. These results are consistent with our experimental expectations. Similarly, we found the same results in animal experiments (Figure 1B): miRNA101a levels were significantly reduced in the LAA epicardial adipose tissues of rats subjected to esophageal pacing to create an AF model, compared to the control group. Additionally, we collected LAA tissues from different patient groups for HE and Masson staining. The HE staining results (Figure 1C) revealed pronounced inflammatory cell infiltration and disorganized cellular structures in the AF group compared to the SR group. Masson staining results (Figure 1D)indicated increased collagen deposition and significantly enhanced fibrosis in the myocardial tissues of the AF group. These findings suggest that myocardial fibrosis is the primary pathological mechanism underlying AF.Due to a handwriting error. A correction has been made to the section Result 3.1 miRNA101a involve of in the process of AF myocardial fibrosis:"In this study, we observed (Figure 1A) a significant reduction in the expression of miRNA101a in the LA A epicardial adipose tissue and peripheral blood of patients with AF compared to the control group. This was determined by RT-PCR analysis of clinical tissue samples from the LAA, showing that miRNA101a lev els were lower in the AF group than in the SR group, with the difference being statistically significant. Th ese results are consistent with our experimental expectations. Similarly, we found the same results in an imal experiments (Figure 1B): miRNA101a levels were significantly reduced in the LAA epicardial adipose tissues of rats subjected to esophageal pacing to create an AF model, compared to the control group. A dditionally, we collected LAA tissues from different patient groups for HE and Masson staining. The HE st aining results (Figure 1C) revealed pronounced inflammatory cell infiltration and disorganized cellular str uctures in the AF group compared to the SR group. Masson staining results (Figure 1D) indicated increas ed collagen deposition and significantly enhanced fibrosis in the myocardial tissues of the AF group. The se findings suggest that myocardial fibrosis is the primary pathological mechanism underlying AF." The original version of this article has been updated.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sihao et al. (2026) studied atrial fibrillation. Patients with atrial fibrillation had significantly lower expression of miRNA101a in the left atrial appendage epicardial adipose tissue and peripheral blood compared to the control group.

synapsesocial.com/papers/6a06b74ce7dec685947aa394https://doi.org/10.3389/fphar.2026.1861200
Ask AI
Helpful
Bookmark
Share
View Full Paper